These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 31476962)

  • 1. Circulating Monocyte Chemoattractant Protein-1 and Risk of Stroke: Meta-Analysis of Population-Based Studies Involving 17 180 Individuals.
    Georgakis MK; Malik R; Björkbacka H; Pana TA; Demissie S; Ayers C; Elhadad MA; Fornage M; Beiser AS; Benjamin EJ; Boekholdt SM; Engström G; Herder C; Hoogeveen RC; Koenig W; Melander O; Orho-Melander M; Schiopu A; Söderholm M; Wareham N; Ballantyne CM; Peters A; Seshadri S; Myint PK; Nilsson J; de Lemos JA; Dichgans M
    Circ Res; 2019 Sep; 125(8):773-782. PubMed ID: 31476962
    [No Abstract]   [Full Text] [Related]  

  • 2. Association of Circulating Monocyte Chemoattractant Protein-1 Levels With Cardiovascular Mortality: A Meta-analysis of Population-Based Studies.
    Georgakis MK; de Lemos JA; Ayers C; Wang B; Björkbacka H; Pana TA; Thorand B; Sun C; Fani L; Malik R; Dupuis J; Engström G; Orho-Melander M; Melander O; Boekholdt SM; Zierer A; Elhadad MA; Koenig W; Herder C; Hoogeveen RC; Kavousi M; Ballantyne CM; Peters A; Myint PK; Nilsson J; Benjamin EJ; Dichgans M
    JAMA Cardiol; 2021 May; 6(5):587-592. PubMed ID: 33146689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetically Determined Levels of Circulating Cytokines and Risk of Stroke.
    Georgakis MK; Gill D; Rannikmäe K; Traylor M; Anderson CD; Lee JM; Kamatani Y; Hopewell JC; Worrall BB; Bernhagen J; Sudlow CLM; Malik R; Dichgans M
    Circulation; 2019 Jan; 139(2):256-268. PubMed ID: 30586705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association among plasma levels of monocyte chemoattractant protein-1, traditional cardiovascular risk factors, and subclinical atherosclerosis.
    Deo R; Khera A; McGuire DK; Murphy SA; Meo Neto Jde P; Morrow DA; de Lemos JA
    J Am Coll Cardiol; 2004 Nov; 44(9):1812-8. PubMed ID: 15519012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monocyte Chemoattractant Protein-1, Inflammatory Biomarkers, and Prognosis of Patients With Ischemic Stroke or Transient Ischemic Attack: Fndings From a Nationwide Registry Study.
    Xu Q; Liu Y; Tian X; Xia X; Zhang Y; Zhang X; Wang Y; Sun P; Meng X; Wang A
    J Am Heart Assoc; 2024 Aug; 13(16):e035820. PubMed ID: 39119971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between plasma monocyte chemoattractant protein-1 concentration and cardiovascular disease mortality in middle-aged diabetic and nondiabetic individuals.
    Piemonti L; Calori G; Lattuada G; Mercalli A; Ragogna F; Garancini MP; Ruotolo G; Luzi L; Perseghin G
    Diabetes Care; 2009 Nov; 32(11):2105-10. PubMed ID: 19641159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating Interleukin-6 Levels and Incident Ischemic Stroke: A Systematic Review and Meta-analysis of Prospective Studies.
    Papadopoulos A; Palaiopanos K; Björkbacka H; Peters A; de Lemos JA; Seshadri S; Dichgans M; Georgakis MK
    Neurology; 2022 Mar; 98(10):e1002-e1012. PubMed ID: 34969940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Monocyte Chemoattractant Protein-1 with Death and Atherosclerotic Events in Chronic Kidney Disease.
    Gregg LP; Tio MC; Li X; Adams-Huet B; de Lemos JA; Hedayati SS
    Am J Nephrol; 2018; 47(6):395-405. PubMed ID: 29874658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations of Adiposity, Circulating Protein Biomarkers, and Risk of Major Vascular Diseases.
    Pang Y; Kartsonaki C; Lv J; Fairhurst-Hunter Z; Millwood IY; Yu C; Guo Y; Chen Y; Bian Z; Yang L; Chen J; Clarke R; Walters RG; Holmes MV; Li L; Chen Z
    JAMA Cardiol; 2021 Mar; 6(3):276-286. PubMed ID: 33263724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel hemostatic factor levels and risk of ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) Study.
    Suri MF; Yamagishi K; Aleksic N; Hannan PJ; Folsom AR
    Cerebrovasc Dis; 2010; 29(5):497-502. PubMed ID: 20299790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monocyte chemotactic protein-1 as a potential biomarker for early anti-thrombotic therapy after ischemic stroke.
    Worthmann H; Dengler R; Schumacher H; Schwartz A; Eisert WG; Lichtinghagen R; Weissenborn K
    Int J Mol Sci; 2012; 13(7):8670-8678. PubMed ID: 22942727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma MCP-1 level and risk for peripheral arterial disease and incident coronary heart disease: Atherosclerosis Risk in Communities study.
    Hoogeveen RC; Morrison A; Boerwinkle E; Miles JS; Rhodes CE; Sharrett AR; Ballantyne CM
    Atherosclerosis; 2005 Dec; 183(2):301-7. PubMed ID: 16285993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating biomarkers and incident ischemic stroke in the Framingham Offspring Study.
    Shoamanesh A; Preis SR; Beiser AS; Kase CS; Wolf PA; Vasan RS; Benjamin EJ; Seshadri S; Romero JR
    Neurology; 2016 Sep; 87(12):1206-11. PubMed ID: 27558379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mortality and Morbidity Effects of Long-Term Exposure to Low-Level PM
    Brunekreef B; Strak M; Chen J; Andersen ZJ; Atkinson R; Bauwelinck M; Bellander T; Boutron MC; Brandt J; Carey I; Cesaroni G; Forastiere F; Fecht D; Gulliver J; Hertel O; Hoffmann B; de Hoogh K; Houthuijs D; Hvidtfeldt U; Janssen N; Jorgensen J; Katsouyanni K; Ketzel M; Klompmaker J; Hjertager Krog N; Liu S; Ljungman P; Mehta A; Nagel G; Oftedal B; Pershagen G; Peters A; Raaschou-Nielsen O; Renzi M; Rodopoulou S; Samoli E; Schwarze P; Sigsgaard T; Stafoggia M; Vienneau D; Weinmayr G; Wolf K; Hoek G
    Res Rep Health Eff Inst; 2021 Sep; 2021(208):1-127. PubMed ID: 36106702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma natriuretic peptides and incidence of subtypes of ischemic stroke.
    Berntsson J; Zia E; Borné Y; Melander O; Hedblad B; Engström G
    Cerebrovasc Dis; 2014; 37(6):444-50. PubMed ID: 25060145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omega-3 Fatty Acids and Incident Ischemic Stroke and Its Atherothrombotic and Cardioembolic Subtypes in 3 US Cohorts.
    Saber H; Yakoob MY; Shi P; Longstreth WT; Lemaitre RN; Siscovick D; Rexrode KM; Willett WC; Mozaffarian D
    Stroke; 2017 Oct; 48(10):2678-2685. PubMed ID: 28830976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of HIV viral load with monocyte chemoattractant protein-1 and atherosclerosis burden measured by magnetic resonance imaging.
    Floris-Moore M; Fayad ZA; Berman JW; Mani V; Schoenbaum EE; Klein RS; Weinshelbaum KB; Fuster V; Howard AA; Lo Y; Schecter AD
    AIDS; 2009 May; 23(8):941-9. PubMed ID: 19318907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monocytes and monocyte chemoattractant protein 1 (MCP-1) as early predictors of disease outcome in patients with cerebral ischemic stroke.
    Bonifačić D; Toplak A; Benjak I; Tokmadžić VS; Lekić A; Kučić N
    Wien Klin Wochenschr; 2016 Jan; 128(1-2):20-7. PubMed ID: 26542133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between post-treatment circulating biomarkers of inflammation and survival among stage II-III colorectal cancer patients.
    Hua X; Kratz M; Malen RC; Dai JY; Lindström S; Zheng Y; Newcomb PA
    Br J Cancer; 2021 Sep; 125(6):806-815. PubMed ID: 34230610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of circulating monocyte chemoattractant protein-1 levels with polycystic ovary syndrome: A meta-analysis.
    Wu Z; Fang L; Li Y; Yan Y; Thakur A; Cheng JC; Sun YP
    Am J Reprod Immunol; 2021 Aug; 86(2):e13407. PubMed ID: 33638245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.